PC
Paolo Cameli
University of Siena, Azienda Ospedaliera Universitaria Senese, University of Florence
Research areas: Medicine · Pulmonary and Respiratory Medicine · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · Asthma and respiratory diseases · Chronic Obstructive Pulmonary Disease (COPD) Research
0000-0001-8639-2882
Employment
-
Università degli Studi di Siena Ricercatori a tempo determinato2021 - 2024
-
University of Siena Senior Researcher2021 - 2024
-
Azienda Ospedaliera Universitaria Senese Medical doctor, Respiratory diseases specialist2020 - 2021
-
Università degli Studi di Siena Assegnisti2019 - 2020
-
University of Siena Temporary Research Fellow2019 - 2020
-
Università degli Studi di Siena Borsisti2018 - 2018
-
Università degli Studi di Siena Borsisti2017 - 2017
-
Università degli Studi di Siena Borsisti2017 - 2017
Education
- 2018 - 2021
-
University of Florence Specialist in Respiratory Diseases2014 - 2018
Projects & Funding
Projects & funding information is unavailable.
Publications (299)
- Adhesion molecules and T cell imbalance in severe eosinophilic asthma: Insights from anti-IL-5R treatment Save
- Geriatric respiratory medicine 2026: from artificial intelligence to personalised management of the multimorbid patient Save
- Biomarkers in ANCA-Associated Vasculitis-Associated Interstitial Lung Disease: A Scoping Review Save
- Baseline dual elevation of fractional exhaled nitric oxide and blood eosinophils is associated with clinical remission in severe eosinophilic asthma treated with biologics: a real-world prospective study Save
- Dual REmission in moderate-to-severe AsthMa and Nasal Polyps: a multicentric observational Phase IV real-life study (DREAM-NP) Save
- Beyond inflammation: alarmins as critical drivers of pulmonary fibrosis Save
- IL-33 Modulates Cytotoxic NK Cell Subsets in Severe Eosinophilic Asthma Save
- Uncovering Sex and Gender Differences in Sarcoidosis: A Systematic Review of Current Evidence Save
- Adding pieces to the puzzle: IL-33 contribution to fibrogenesis in chronic lung allograft dysfunction Save
- Combined use of serum KL-6 and respiratory functional parameters for identifying fibrotic lung damage in SARS-CoV-2-induced interstitial pneumonia Save
- Dupilumab in severe asthma–COPD overlap: real-life experience on a case series Save
- Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study Save
- Longitudinal multimodal assessment of pulmonary nodules in fibrosing interstitial lung diseases: a retrospective study Save
- Sarcoidosis and Systemic Comorbidities: Sex-Related Differences in a Multicenter Italian Cohort Save
- T2-Reg: a regional web registry on Th2-mediated diseases Save
- Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a post hoc analysis of the ANANKE study Save
- Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study Save
- Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey Save
- Epidemiology of idiopathic pulmonary fibrosis: a population registry-based study Save
- From Guillain–Barré–Like Neuropathy to EGPA: ANCA Testing and Kidney Biopsy as Diagnostic Turning Points Save